Luye Pharma Group Ltd. (OTCMKTS:LYPHF) Sees Large Drop in Short Interest

Luye Pharma Group Ltd. (OTCMKTS:LYPHF) saw a large decline in short interest during the month of September. As of September 30th, there was short interest totaling 2,299,900 shares, a decline of 32.6% from the September 15th total of 3,413,800 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ? days. Based on an average daily volume of 0 shares, the short-interest ratio is presently ? days.

Luye Pharma Group Price Performance

Shares of LYPHF opened at $0.27 on Friday. The firm’s 50 day moving average is $0.27 and its 200-day moving average is $0.27. Luye Pharma Group has a 12-month low of $0.26 and a 12-month high of $0.27.

Luye Pharma Group Company Profile

Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian cancer and carcinoma of ovary; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers; and Xuezhikang, a lipid-regulating drug for the treatment of hypercholesterolaemia.